Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion | Reuters

By Michael Erman and Natalie Grover Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc (ZLTQ.O), adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.Allergan said it would benefit from the cross-selling opportunities for consumers of Zeltiq's CoolSculpting System, which uses cooling to kill fat cells, as well as customers of its own facial injectible products.'Demand for both procedures is high and this is similar to pouring more gas on the fire,' Allergan Chief Commercial Officer Bill Meury said on a call with investors.The Botox maker agreed to pay $56.50 per Zeltiq share, or a premium of 14.4 percent to the company's Friday close. Zeltiq's shares rose 12.8 percent to $55.72 in midday trading on Monday.Zeltiq's process was created after two scientists at Harvard University noticed that some children who ate popsicles got dimples in their cheeks, according to Zeltiq's website

Reuters February 14, 2017 00:45:06 IST
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
| Reuters

Allergan to buy fatfighter Zeltiq Aesthetics for 248 billion
 Reuters

By Michael Erman and Natalie Grover

Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc (ZLTQ.O), adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.Allergan said it would benefit from the cross-selling opportunities for consumers of Zeltiq's CoolSculpting System, which uses cooling to kill fat cells, as well as customers of its own facial injectible products."Demand for both procedures is high and this is similar to pouring more gas on the fire," Allergan Chief Commercial Officer Bill Meury said on a call with investors.The Botox maker agreed to pay $56.50 per Zeltiq share, or a premium of 14.4 percent to the company's Friday close. Zeltiq's shares rose 12.8 percent to $55.72 in midday trading on Monday.Zeltiq's process was created after two scientists at Harvard University noticed that some children who ate popsicles got dimples in their cheeks, according to Zeltiq's website. They discovered that the popsicles were eliminating small pockets of fat cells.

Insurers do not cover Zeltiq's CoolSculpting System, meaning the bulk of the company's more than $350 million in 2016 sales was paid directly by consumers. Allergan said it has been targeting so-called "cash-pay" businesses, which is a model it uses for some of its Botox sales and other aesthetic offerings.CoolSculpting is approved by the U.S. Food and Drug Administration. Dublin-based Allergan, led by its Chief Executive Brent Saunders, has struck a number of deals since its $160 billion merger with Pfizer Inc (PFE.N) collapsed in April. Those have included its $2.9 billion purchase of regenerative medecine business LifeCell Corp and the $1.5 billion acquisition of biotech company Vitae Pharmaceuticals.

Earlier this month, Saunders set lofty expectations for its injection Kybella - used to diminish fat under the chin, leaving surrounding tissue largely unaffected - for 2017, and expressed an interest in continued deal making.In the three months ended Dec. 31, total medical aesthetic product sales accounted for 28 percent of Allergan's net revenue.

Allergan, which estimates that body contouring is a $4 billion market, said the transaction is expected to close in the second half of 2017.Shares of Allergan rose $1.27, or 0.5 percent, to $247.63 in midday trading on the New York Stock Exchange.Moelis & Co is Allergan's financial adviser, while Debevoise & Plimpton LLP serve as legal counsel. Guggenheim Securities is Zeltiq's financial adviser, while Cooley LLP will provide legal advice. (Reporting by Michael Erman in New York and Natalie Grover in Bengaluru; Editing by Shounak Dasgupta, Martina D'Couto and Frances Kerry)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.